Journal article
The Role of Pharmacogenomics in Opioid Prescribing
AK Wong, AA Somogyi, J Rubio, J Philip
Current Treatment Options in Oncology | Published : 2022
Open access
Abstract
Pharmacogenomics is increasingly important to guide objective, safe, and effective individualised prescribing. Personalised prescribing has revolutionised treatments in the past decade, allowing clinicians to maximise drug efficacy and minimise adverse effects based on a person’s genetic profile. Opioids, the gold standard for cancer pain relief, are among the commonest medications prescribed in palliative care practice. This narrative review examines the literature surrounding opioid pharmacogenomics and its applicability to the palliative care cancer population. There is currently limited intersection between the fields of palliative care and pharmacogenomics, but growing evidence presents..
View full abstractRelated Projects (1)
Grants
Awarded by Bethlehem Griffiths Research Foundation
Funding Acknowledgements
Open Access funding enabled and organized by CAUL and its Member Institutions. This work was supported via the Bethlehem Griffiths Research Foundation Grant and the Russell Cole Memorial Research Award (Australian & New Zealand College of Anaesthetists).